This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (21)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Use in Patients with Erythrocytosis and Ischemic Heart Disease

G. E. BURCH, MD; N. P. DE PASQUALE, MD

Arch Intern Med. 1963;111(6):687-695.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

It has been known for some time that patients with polycythemia vera are predisposed to angina pectoris and myocardial infarction.¹ A recent study described a group of patients with angina pectoris or acute myocardial infarction, or both, who had moderate erythrocytosis but in whom hematologic studies failed to demonstrate any evidence of polycythemia vera.² Reduction of the hematocrit by phlebotomy decreased the frequency of anginal attacks in some patients. In an effort to learn the relationship of hematocrit to myocardial infarction the hematocrit levels of 100 men and 120 women with acute myocardial infarction were compared with those of age-matched subjects without clinical evidence of coronary artery disease.^3,4 It was found that the hematocrit levels for the men and women with acute myocardial infarction were significantly higher than those for the control subjects (Fig. 1).

The purpose of this paper is to present evidence that phlebotomy may . . . [Full Text PDF of this Article]

Author Affiliations
NEW ORLEANS

From the Department of Medicine of the Tulane University School of Medicine and the Charity Hospital of Louisiana.

Footnotes
Received for publication Oct. 29, 1962; accepted Nov. 1.

Supported by grants from the U.S. Public Health Service.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?